Pentwater Capital Management’s Medicines Co MDCO Stock Holding History

Pentwater Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-780,500	Closed	-$66.3M	–	190
2019 Q4	$66.3M	Buy	+780,500	New	+$52M	1.08%	19

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Pentwater Capital Management's MDCO Position: Q1 2020 in Review

Pentwater Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 780,500 shares — an estimated $66.3M sold.

Pentwater Capital Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $66.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Pentwater Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Pentwater Capital Management sold 780,500 Medicines Co shares in Q1 2020, an estimated $66.3M.
Pentwater Capital Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Pentwater Capital Management's Medicines Co position peaked at $66.3M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Pentwater Capital Management's 13F filing for Q1 2020, filed 15 May 2020.